Israel Englander’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History

Israel Englander’s Portfolio VRPX Stock Details VRPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,075	Closed	-$26.5K	–	6513
2025 Q1	$26.5K	Buy	+22,075	New	+$135K	﹤0.01%	5602

Other funds holding VRPX

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Israel Englander's VRPX Position: Q2 2025 in Review

Israel Englander sold out of Virpax Pharmaceuticals, Inc. Common Stock (VRPX) in Q2 2025, closing a stake of 22,075 shares — an estimated $26.5K sold.

Israel Englander first reported a position in VRPX in Q1 2025 and held it in 1 quarter. The position peaked at $26.5K in Q1 2025. 1 fund tracked by Wall St. Rank holds VRPX as of Q2 2025.

Israel Englander reported no remaining Virpax Pharmaceuticals, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Israel Englander sold 22,075 Virpax Pharmaceuticals, Inc. Common Stock shares in Q2 2025, an estimated $26.5K.
Israel Englander first reported a position in Virpax Pharmaceuticals, Inc. Common Stock in Q1 2025 and held it in 1 quarter.
Israel Englander's Virpax Pharmaceuticals, Inc. Common Stock position peaked at $26.5K in Q1 2025.
1 fund tracked by Wall St. Rank held Virpax Pharmaceuticals, Inc. Common Stock as of Q2 2025.

Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.